Question | Discussion | References | CME Credit

Case 3: References

  1. Gerber JG, Rhodes RJ, Gal J. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. Chirality. 2004;16:36-44.
    [The following link will open in a new window. PubMed Abstract]
  2. Gourevitch MN, Friedland GH. Interactions between methadone and medications used to treat HIV infection: A review. Mt Sinai J Med. 2000; 67:429-36.
    [The following link will open in a new window. PubMed Abstract]
  3. Clarke SM, Mulcahy FM, Tjia J, Reynolds HE, Gibbons SE, Barry MG, Back DJ. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clin Infect Dis. 2001;33:1595-7.
    [The following link will open in a new window. PubMed Abstract]
  4. Clarke SM, Mulcahy FM, Tjia J, Reynolds HE, Gibbons SE, Barry MG, Back DJ. The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol. 2001; 51:213-7.
    [The following link will open in a new window. PubMed Abstract]
  5. McCance-Katz EF, Farber S, Selwyn PA, O'Connor A. Decrease in methadone levels with nelfinavir mesylate. Am J Psychiatry. 2000;157:481.
    [The following link will open in a new window. PubMed Abstract]
  6. Clarke S, Mulcahy F, Bergin C, Reynolds H, Boyle N, Barry M, Back DJ. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir. Clin Infect Dis. 2002;34:1143-5.
    [The following link will open in a new window. PubMed Abstract]
  7. McCance-Katz EF, Rainey PM, Friedland G, Jatlow P. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis. 2003;37:476-82.
    [The following link will open in a new window. PubMed Abstract]
  8. Hendrix CW, Wakeford J, Wire MB, et al. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects. Pharmacotherapy. 2004;24:1110-21.
    [The following link will open in a new window. PubMed Abstract]
  9. Cantilena S, Mcrea J, Blazes D, Winchell G, Carides A, Royce C, et al. Lack of pharmacokinetic interaction between indinavir and methadone (Abstract PI-74). Clin Pharmacol Ther. 1999;65:135.

[Back to Case 3 Question | Back to Discussion]

CME Credit | Back to Top